CO [China Cord Blood] SC TO-C: SCHEDULE TO (Rule 14d-100) Tender Offer Statement under

Ticker: CO, Company: China Cord Blood Corp, Type: SC TO-C, Date: 2010-09-13
Original SEC Filing: Click here


Webplus: CO/20100913/SC_TO-C_1/1/000.htm SEC Original: v196443_scto-c.htm
SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) CHINA CORD BLOOD CORPORATION (Name of Subject Company (Issuer) and Name of Filing Person (Issuer)) (Title of Class of Securities) KYG211071181 ) Albert Chen +852 3605 8180 albert.chen@chinacordbloodcorp.com 48th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. (Name, Address and Telephone Number of Person




Webplus: CO/20100913/SC_TO-C_1/2_EX-99.1/000.htm SEC Original: v196443_ex99-1.htm
HONG KONG, China, September 13, 2010 – China Cord Blood Corporation Ms. Ting Zheng, Chairperson and CEO of China Cord Blood Corporation commented, “The proposed exchange offer will streamline and simplify our shareholding structure as well as corporate structure.” About China Cord Blood Corporation http://www.chinacordbloodcorp.com China Cord Blood Corporation is the first and largest cord blood banking operator in China



Company Information:

Ticker: CO, Company: China Cord Blood Corp, Type: SC TO-C, Date: 2010-09-13CIK: 0001467808, Location: K3, SIC: 6770, SIC Desc: BLANK CHECKS
Business Phone & Address:
48 FL., BANK OF CHINA TOWER, 1 GARDEN ROAD
CENTRAL HONG KONG, K3 000000

Home Page Forums

By | 2016-02-29T16:39:27+00:00 September 13th, 2010|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

About the Author:

Leave A Comment

Skip to toolbar